Morgan Stanley Nephros Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Nephros Inc stock. As of the latest transaction made, Morgan Stanley holds 1,915 shares of NEPH stock, worth $8,196. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,915

Previous 5,423 64.69%

Holding current value

$8,196

Previous $9,000 22.22%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$1.8 - $5.0 $6,314 - $17,540	-3,508 Reduced 64.69%	1,915 $7,000
Q1 2024 Aug 16, 2024	SELL	$2.11 - $3.78 $59,820 - $107,166	-28,351 Reduced 83.94%	5,423 $11,000
Q1 2024 May 15, 2024	SELL	$2.11 - $3.78 $59,820 - $107,166	-28,351 Reduced 83.94%	5,423 $11,000
Q4 2023 Aug 16, 2024	BUY	$1.46 - $3.91 $41,392 - $110,852	28,351 Added 522.79%	33,774 $116,000
Q4 2023 Feb 13, 2024	BUY	$1.46 - $3.91 $26,983 - $72,264	18,482 Added 120.86%	33,774 $116,000
Q3 2022 Nov 14, 2022	SELL	$0.91 - $1.87 $2,695 - $5,538	-2,962 Reduced 16.23%	15,292 $14,000
Q2 2022 Oct 27, 2022	BUY	$1.47 - $4.63 $15,771 - $49,675	10,729 Added 142.58%	18,254 $28,000
Q2 2022 Aug 15, 2022	BUY	$1.47 - $4.63 $15,771 - $49,675	10,729 Added 142.58%	18,254 $28,000
Q1 2022 Oct 27, 2022	SELL	$3.89 - $6.12 $41,735 - $65,661	-10,729 Reduced 58.78%	7,525 $33,000
Q1 2022 May 13, 2022	BUY	$3.89 - $6.12 $4,080 - $6,419	1,049 Added 16.2%	7,525 $33,000
Q4 2021 Feb 14, 2022	SELL	$5.87 - $8.46 $43,209 - $62,274	-7,361 Reduced 53.2%	6,476 $38,000
Q3 2021 Nov 15, 2021	BUY	$7.6 - $10.01 $105,161 - $138,508	13,837 New	13,837 $121,000

Others Institutions Holding NEPH

# of Institutions

Shares Held

4.37M

Call Options Held

Put Options Held

View Full List

About NEPHROS INC

Ticker NEPH
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 10,318,800
Market Cap $44.2M
Description
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...

More about NEPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account